Rosa Ambrosio
About Rosa Ambrosio
Rosa Ambrosio serves as the Director of Sales Europe at Suvoda, where she has worked since 2021. With extensive experience in the pharmaceutical and biotechnology sectors, she specializes in optimizing clinical trial processes.
Work at Suvoda
Rosa Ambrosio has been serving as the Director of Sales Europe at Suvoda since 2021. In this role, she focuses on the pharmaceutical and biotechnology sectors, leveraging her expertise to enhance sales strategies across Europe. Suvoda is recognized for its software solutions that manage complex trial designs and optimize clinical trial supply chains. Ambrosio's leadership contributes to the company's mission of improving clinical trial processes.
Previous Experience in Sales
Before joining Suvoda, Rosa Ambrosio worked as a Sales Manager at Dinbeat for a brief period in 2021. Prior to that, she held the position of Strategic Account Manager at Clarivate Analytics from 2016 to 2020, where she managed key accounts and developed strategic initiatives. Additionally, she worked at Thomson Reuters as a Strategic Account Manager from 2009 to 2016, focusing on client relationships and sales growth in the Barcelona area.
Education and Expertise
Rosa Ambrosio studied at the University of East Anglia, where she gained foundational knowledge that supports her career in sales and account management. She possesses expertise in optimizing clinical trial processes, which is critical for accelerating drug market entry. Her educational background and professional experience equip her to navigate the complexities of the pharmaceutical and biotechnology industries.
Background in the Pharmaceutical Sector
Rosa Ambrosio has a strong background in the pharmaceutical and biotechnology sectors, demonstrated through her various roles in sales and account management. Her experience spans over a decade, during which she has developed a deep understanding of the industry's dynamics. This background enables her to effectively address the challenges faced by clients in clinical trial management.